Baseline characteristics
| Clinical data | BMT (n = 10) | Control (n = 10) |
|---|---|---|
| *By left ventriculography. | ||
| Data are mean (SD) or number. All differences between groups are non-significant. | ||
| ACE, angiotensin-converting enzyme; BMT, bone marrow cell transplantation; CAD, coronary artery disease; CK, creatinine kinase; LAD, left anterior descending; LCX, left circumflex; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery; TIMI, Thrombolysis In Myocardial Infarction; TnT, troponin T; VD, vessel disease. | ||
| Age (years) | 58 (11) | 59 (8) |
| Men/women | 8/2 | 10/0 |
| Hypertension | 5 | 7 |
| Diabetes | 3 | 4 |
| Smoking | 8 | 7 |
| CAD (1-VD/2-VD/3-VD) | 7/2/1 | 7/3/0 |
| Infarct territory (anterior/inferior) | 7/3 | 7/3 |
| Affected vessel (LAD/LCX/RCA) | 7/1/2 | 7/0/3 |
| Duration from MI to PCI (h) | 7.9 (3.8) | 7.1 (3.1) |
| TIMI III flow after reperfusion | 10 | 10 |
| LVEF during PCI (%)* | 56.45 (8.73) | 58.21 (12.59) |
| Maximum CK after PCI (U/l) | 2642 (1219) | 3511 (2872) |
| Maximum CK-MB after PCI (U/l) | 299 (184) | 410 (431) |
| Maximum TnT (ng/ml) | 11.16 (6.78) | 14.75 (9.33) |
| White blood cell count (×109/l) | ||
| Before PCI | 10.6 (3.7) | 8.7 (3.2) |
| 24 h after cell therapy | 11.36 (1.86) | 9.71 (2.14) |
| C reactive protein (mg/l) | 139 (128) | 89 (45.2) |
| Drugs on discharge | ||
| Aspirin | 10 | 10 |
| Nitrate | 10 | 10 |
| ACE inhibitor | 10 | 10 |
| β blocker | 10 | 10 |
| Statin | 10 | 10 |
| Clopidogrel | 10 | 10 |